The subsequent advent of arsenic trioxide in 1994 marked an additional milestone in APL treatment and has inspired the design of rationally targeted, chemotherapy-free front-line treatment ...

the HKU research team successfully translated this Hong Kong invention into clinical practice by incorporating oral-ATO into the treatment plan of APL patients. Extensive clinical studies of oral ...

APL is turning from a fatal disease to a ... underlying leukaemia relapse to improve transplantation treatment. We also plan to explore new targets and find more biomarkers for developing ...